297 related articles for article (PubMed ID: 23679825)
1. MicroRNAs in myeloid malignancies.
Gordon JE; Wong JJ; Rasko JE
Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNAs in hematological malignancies.
Fatica A; Bozzoni I
Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in cancer: personalizing diagnosis and therapy.
Nana-Sinkam SP; Fabbri M; Croce CM
Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of molecular haematology: an overview.
Bain BJ
J Assoc Physicians India; 2007 Jul; 55():503-6. PubMed ID: 17907501
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in hematological malignancies.
Lawrie CH
Blood Rev; 2013 May; 27(3):143-54. PubMed ID: 23623930
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic epigenetics: an emerging clinical approach to hematologic malignancies.
Clin Adv Hematol Oncol; 2005 Mar; 3(3 Suppl 1):1-10; quiz 11-2. PubMed ID: 21438190
[No Abstract] [Full Text] [Related]
7. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
Wang LQ; Liang R; Chim CS
Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
[TBL] [Abstract][Full Text] [Related]
8. Hematological malignancies: role of miRNAs and their in silico aspects.
Omer A; Yadav NK; Singh P; Singh RK
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
[TBL] [Abstract][Full Text] [Related]
9. Exploring the major cross-talking edges of competitive endogenous RNA networks in human Chronic and Acute Myeloid Leukemia.
Sen K; Bhattacharyya D; Sarkar A; Das J; Maji N; Basu M; Ghosh Z; Ghosh TC
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1883-1892. PubMed ID: 29902552
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
So CC; Ma ES; Wan TS; Yip SF; Chan LC
Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
[No Abstract] [Full Text] [Related]
11. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies.
Wihlidal P; Varga F; Pfeilstöcker M; Karlic H
Leuk Res; 2006 Oct; 30(10):1241-8. PubMed ID: 16387359
[TBL] [Abstract][Full Text] [Related]
13. [Loss of junB expression causes a myeloproliferative syndrome resembling chronic myeloid leukemia].
Jochum W; Passegue E; Wagner EF
Verh Dtsch Ges Pathol; 1999; 83():216-7. PubMed ID: 10714213
[TBL] [Abstract][Full Text] [Related]
14. Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.
Koldehoff M; Steckel NK; Beelen DW; Elmaagacli AH
Clin Exp Med; 2006 Mar; 6(1):45-7. PubMed ID: 16550344
[No Abstract] [Full Text] [Related]
15. Genetics of myeloid malignancies: pathogenetic and clinical implications.
Fröhling S; Scholl C; Gilliland DG; Levine RL
J Clin Oncol; 2005 Sep; 23(26):6285-95. PubMed ID: 16155011
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
17. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
Ostrovsky O; Korostishevsky M; Levite I; Leiba M; Galski H; Vlodavsky I; Nagler A
Leukemia; 2007 Nov; 21(11):2296-303. PubMed ID: 17611567
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal aberrations and fusion genes in myeloid malignancies.
Gianfelici V; Lahortiga I; Cools J
Expert Rev Hematol; 2012 Aug; 5(4):381-93. PubMed ID: 22992233
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic applications of miRNA-based technology in hematological malignancies.
Barbarotto E; Calin GA
Curr Pharm Des; 2008; 14(21):2040-50. PubMed ID: 18691114
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of miRNA genes in acute leukemia.
Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]